Michael Attar

Michael Attar is an experienced business development executive with a strong background in the biotechnology and financial sectors. Currently serving as Senior Vice President and Head of Business Development at Beam Therapeutics since June 2021, Michael previously founded and led Attar & Associates from 2019 to June 2021, and held roles such as Vice President of Corporate Development at Sienna Biopharmaceuticals and Executive Director of Business Development at Celgene. With a history that includes senior leadership positions at Abraxis BioScience, Ixia, Tekelec, and Morgan Stanley, Michael has a robust expertise in corporate strategy and investor relations. Academic credentials include an M.B.A. in Finance, Strategy, and Accounting from Northwestern University's Kellogg School of Management, and a B.A. in Quantitative Studies from The Johns Hopkins University.